Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View TRHC analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12-month price objectives for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $6.00 to $10.00. On average, they expect the company's stock price to reach $8.00 in the next year. This suggests that the stock has a possible downside of 22.4%.
View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts.

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC stock has increased by 108.3% and is now trading at $10.31.
View the best growth stocks for 2023 here.

Tabula Rasa HealthCare saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 763,200 shares, a drop of 21.2% from the August 15th total of 969,000 shares. Based on an average daily volume of 376,400 shares, the short-interest ratio is currently 2.0 days. Currently, 3.2% of the shares of the company are sold short.
View Tabula Rasa HealthCare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our TRHC earnings forecast.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) posted its quarterly earnings results on Monday, August, 7th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.30) by $0.24. The company earned $90.04 million during the quarter, compared to the consensus estimate of $88.82 million.

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Tabula Rasa HealthCare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (4.28%), Kent Lake Capital LLC (2.22%), Acadian Asset Management LLC (1.66%), Portside Wealth Group LLC (1.59%), Kennedy Capital Management LLC (1.34%) and Repertoire Partners LP (1.29%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends.

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRHC stock can currently be purchased for approximately $10.31.

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $278.99 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($3.85) on an earnings per share basis.

The company employs 1,027 workers across the globe.

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.